Nada Giuffrida and Kym Ellis, Hallam Internet, offer advice on how to redefine pharmaceutical digital marketing strategies
Nada Giuffrida and Kym Ellis, Hallam Internet
In 2015 many pharmaceutical firms companies still remain concerned about managing or creating social and digital marketing activities. Some of them may have not yet fully embraced the new channels and digital revolution. However, patients out there are increasingly demanding and expecting them to be engaged – those firms that have are reaping the rewards.
Consumers today are highly active social beings. Research has found that the average American goes to the doctor three times a year but spends 52 hours online searching for health information. We all want medical advice fast and we are happy to consult an array of sources including friends and family, social media, news outlets, blogs, Wikipedia, pharma company websites and everything in between.
Millennials and the younger generations of consumers – the most tech-savvy of all – have an effect on the pharmaceutical companies. Adopting new communication and marketing strategies are needed more than ever now.
Start with a strategy
Any B2B digital marketing strategy needs to be carefully planned taking into consideration the industry, its challenges and crucially, the overall strategy of the business. The wider pharma industry is an interesting case. Due of the nature of the industry there are more rules and regulations, which initially caused a slower uptake in digital marketing compared with some other industries.
According to PMLIVE, the biggest challenge facing digital marketing efforts for pharmaceutical companies in 2014 was an ‘unclear strategy’. Getting internal buy-in was also listed as a challenge –ROI is difficult to monitor when you are not using the internet to sell products directly and unrealistic KPIs can be discouraging.
The following six key areas for consideration all contribute to a clearly defined strategy:
SEO
Search engine optimisation is an important strategy which focuses on landing page prominence and conversions. A conversion doesn’t have to be a sale, it could be an enquiry, a newsletter sign-up or a download of an information guide. These types of conversions are more appropriate to non-ecommerce websites.
It takes time and patience to gain results but this is where you can use industry expertise alongside an in-depth website review and thorough keyword research to ensure your website is ranking well in the search engine results pages.
Reviewing your website for optimisation purposes is an ongoing strategy. Actions could include updating the structure of your website, its content, or both. Ultimately the goal is to attract high quality, relevant traffic to the website.
It is also beneficial to conduct an analysis of competitor websites to see how they are performing, as this is essentially what you are up against.
PPC
PPC (or Pay Per Click) advertising is where a lot of external restrictions come into play. Google has a comprehensive adwords policy on healthcare and medicine restrictions, which includes restrictions that vary in different countries. There is also a pre-authorisation process for some healthcare related content.
Traditionally, PPC can be used to achieve immediate results in terms of ROI and can be very successful to advertise particular campaigns over a specified time. However, these restrictions make it much more difficult in the pharma industry. It would be possible to run PPC ads for pharmaceutical news, for example, but not products.
Whether or not to use PPC as a digital marketing strategy needs to be considered taking this into account.
Content marketing
The internet is the starting point for most people researching information. Digital Pharma reported that ‘over a 12 month period, 72% of internet users reported that they looked online for information about health.’ This is a great opportunity for content marketing in the pharmaceutical industry.
Brands can take advantage of this by creating content to inform and engage their audience. In the pharma industry, not only is this a great B2B marketing strategy, it also allows you to promote a positive brand message to the end user.
For example, Gsk has a section of the website called ‘our stories’ which has a variety of content about health, business strategy, the environment and social responsibility.
Social media
Engaging with your audience using social media as part of a B2B marketing strategy is increasingly popular. Some pharmaceuticals such as Eli Lilly and Gsk are already using platforms like Facebook and Twitter. It is a great way to promote your content marketing efforts, start conversations and listen to what customers and end users are talking about.
Email is a great channel for more of a targeted approach which helps to promote retention and loyalty. With the right time and resource you can segment your email marketing list into subsets of healthcare professionals, end users and individuals. This allows you to send more personalised emails based on market research, user-defined interests or behaviour.
Digital PR
Historically pharmaceutical firms have relied heavily on traditional public relations strategies and tactics to talk to their patients, including conference sponsorships and third-party advocacy groups. Although these are very important tools, we believe they are no longer enough. Bloggers have become as important and influential as editors and journalists. Online advice and articles on highly rated sites have never been more popular.
Conclusion
Get ahead of the game and learn about all the innovative digital marketing tools at your disposal. Don’t let the fear of the unknown stopping you from meeting more customers. Redefine a clear digital marketing strategy by deciding which channels are most appropriate for your business goals and set realistic targets.